146 related articles for article (PubMed ID: 22341854)
1. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
2. TIS21/(BTG2) negatively regulates estradiol-stimulated expansion of hematopoietic stem cells by derepressing Akt phosphorylation and inhibiting mTOR signal transduction.
Kim BC; Ryu MS; Oh SP; Lim IK
Stem Cells; 2008 Sep; 26(9):2339-48. PubMed ID: 18556508
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
5. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
[TBL] [Abstract][Full Text] [Related]
6. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
7. c-myc but not Hif-1α-dependent downregulation of VEGF influences the proliferation and differentiation of HL-60 cells induced by ATRA.
Song G; Li Y; Zhang Z; Ren X; Li H; Zhang W; Wei R; Pan S; Shi L; Bi K; Jiang G
Oncol Rep; 2013 Jun; 29(6):2378-84. PubMed ID: 23588859
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
9. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
10. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
12. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells.
Domínguez-Cáceres MA; García-Martínez JM; Calcabrini A; González L; Porque PG; León J; Martín-Pérez J
Oncogene; 2004 Sep; 23(44):7378-90. PubMed ID: 15286700
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death.
Hong JW; Ryu MS; Lim IK
J Biol Chem; 2005 Jun; 280(22):21256-63. PubMed ID: 15788397
[TBL] [Abstract][Full Text] [Related]
14. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
15. The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells.
Matkovic K; Brugnoli F; Bertagnolo V; Banfic H; Visnjic D
Leukemia; 2006 Jun; 20(6):941-51. PubMed ID: 16617325
[TBL] [Abstract][Full Text] [Related]
16. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
18. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
[TBL] [Abstract][Full Text] [Related]
19. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
[TBL] [Abstract][Full Text] [Related]
20. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]